Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Harmony Biosciences Holdings, Inc.
IPO Date: August 19, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $1.85B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.80 | 2.14%
Avg Daily Range (30 D): $0.37 | 1.10%
Avg Daily Range (90 D): $0.53 | 1.63%
Institutional Daily Volume
Avg Daily Volume: .4M
Avg Daily Volume (30 D): .47M
Avg Daily Volume (90 D): .51M
Trade Size
Avg Trade Size (Sh.): 53
Avg Trade Size (Sh.) (30 D): 42
Avg Trade Size (Sh.) (90 D): 44
Institutional Trades
Total Inst.Trades: 1,858
Avg Inst. Trade: $2.28M
Avg Inst. Trade (30 D): $2.95M
Avg Inst. Trade (90 D): $3.08M
Avg Inst. Trade Volume: .06M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.82M
Avg Closing Trade (30 D): $4.03M
Avg Closing Trade (90 D): $4.2M
Avg Closing Volume: 77.18K
   
News
Apr 8, 2025 @ 5:00 PM
Developmental and Epileptic Encephalopathies Marke...
Source: Delveinsight
Jan 22, 2025 @ 6:00 PM
5-HT2 Agonist Clinical Trial Pipeline Appears Robu...
Source: Delveinsight
Dec 19, 2024 @ 6:00 PM
Comprehensive Market Analysis of Latest Published ...
Source: Delveinsight
Oct 14, 2024 @ 2:46 PM
Dravet Syndrome Drug Pipeline Research Report 2024...
Source: Researchandmarkets.Com
Aug 6, 2024 @ 12:45 PM
Harmony Biosciences Holdings, Inc. (HRMY) Surpasse...
Source: Zacks.Com
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $2.67 $.79 $.87
Diluted EPS $2.62 $.78 $.85
Revenue $ 744.85M $ 184.73M $ 201.27M
Gross Profit $ 583.53M $ 152.74M $ 146.86M
Net Income / Loss $ 152.72M $ 45.56M $ 49.48M
Operating Income / Loss $ 195.04M $ 56.25M $ 55.73M
Cost of Revenue $ 161.33M $ 31.99M $ 54.41M
Net Cash Flow $ 156.02M $ 36M $ 65.63M
PE Ratio 0.00